Daniel Teper
Direktor/Vorstandsmitglied bei CROSSJECT
Ursprung des Netzwerks ersten Grades von Daniel Teper
| Einheit | Art der Einheit | Industrie | |
|---|---|---|---|
| Private Company | Pharmaceuticals: Major | 27 | |
Cytovia Therapeutics, Inc.
 Cytovia Therapeutics, Inc. BiotechnologyHealth Technology Cytovia Therapeutics, Inc. engages in transformational immunotherapies for cancer and severe acute infectious diseases. Its products include Multi-Specific NK Engager Antibodies and iPSC CAR NK cells. The company was founded by Daniel Teper, Gilles Seydoux, and Massimo Radaelli and is headquartered in New York, NY.
10
| Private Company | Biotechnology | 10 |
GlaxoSmithKline LLC
 GlaxoSmithKline LLC Pharmaceuticals: MajorHealth Technology GlaxoSmithKline LLC engages in discovering, developing, and delivering medicines, vaccines, and other healthcare products. It offers prescription medicines that treat various diseases, including cancer, HIV/AIDS, depression, diabetes, high blood pressure, herpes, asthma, migraine, and heart diseases, as well as stomach and skin problems, infections, and flu. It also provides vaccines for children and adults; and over-the-counter products. The company was founded in 1929 and is headquartered in Philadelphia, PA.
10
| Subsidiary | Pharmaceuticals: Major | 10 |
| Public Company | Medical Specialties | 7 | |
Oxygen Therapy, Inc.
 Oxygen Therapy, Inc. Pharmaceuticals: MajorHealth Technology Oxygen Therapy, Inc. is an early stage pharmaceutical company, which engages in the development, manufacture, and commercialization of an innovative platform of oxygen therapeutic treatments for hypoxic conditions and necrosis prevention. Its product pipeline includes OTI-629, an anti-necrosis drug; and OTI-1011, a resuscitative agent for wound healing applications. The company was founded by David Platt on May 20, 2016 and is headquartered Newton, MA.
6
| Private Company | Pharmaceuticals: Major | 6 |
Vector Therapeutics, Inc.
 Vector Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Vector Therapeutics, Inc. is a commercial-stage specialty pharmaceutical company. The firm engages in the acquisition, development, and commercialization of treatments for a variety of cancers, with a primary focus on leukemia. Its product portfolio consists initially of drugs targeting different stages and sub-types of Acute Myeloid Leukemia. The company was founded by Daniel Teper and is headquartered in New York, NY.
4
| Private Company | Pharmaceuticals: Major | 4 |
Cytovia Holdings, Inc.
4
| Private Company | 4 |
Unternehmensgrafik - zweiten Grades
Beziehungen zu mehreren Unternehmen
Unternehmensverbindungen über das persönliche Netzwerk von Daniel Teper
| Unternehmen | Sektor | Verknüpfte Personen | Hauptposition |
|---|---|---|---|
| CELGENE | Biotechnology | Director/Board Member Chief Tech/Sci/R&D Officer | |
| ENZON PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Chief Executive Officer Corporate Officer/Principal | |
| JOHNSON & JOHNSON | Pharmaceuticals: Major | Sales & Marketing Corporate Officer/Principal | |
| MERCK & CO., INC. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
| BOSTON SCIENTIFIC CORPORATION | Medical Specialties | Corporate Officer/Principal Chief Tech/Sci/R&D Officer | |
| VERNALIS | Pharmaceuticals: Major | Chief Executive Officer Director/Board Member | |
F. Hoffmann-La Roche Ltd.
 F. Hoffmann-La Roche Ltd. Pharmaceuticals: MajorHealth Technology F. Hoffmann-La Roche Ltd. manufactures pharmaceutical products. It offers pharmaceutical drugs, pharmaceutical instruments, and diagnostics solutions. The company was founded by Fritz Hoffmann-La Roche on October 1, 1896 and is headquartered in Basel, Switzerland. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
| GALECTIN THERAPEUTICS INC. | Biotechnology | Director/Board Member Chief Executive Officer Director/Board Member | |
| SANOFI | Miscellaneous Commercial Services | Corporate Officer/Principal Corporate Officer/Principal | |
Executive Leadership Council, Inc.
 Executive Leadership Council, Inc. Miscellaneous Commercial ServicesCommercial Services Executive Leadership Council, Inc. operates as a preeminent member organization for the development of global black leaders. It increase the number of successful black executives both domestically and internationally by adding value to their development, leadership, and philanthropic endeavors throughout the life-cycle of their careers thereby strengthening their companies, organizations and communities. The company was founded in 1986 and is headquartered in Alexandria, VA. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
| GSK PLC | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer Corporate Officer/Principal Corporate Officer/Principal | |
| University of Pittsburgh | College/University | Masters Business Admin | |
| ACTELION | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
| Drexel University | College/University | Undergraduate Degree Undergraduate Degree | |
| University of California, Los Angeles | College/University | Graduate Degree | |
| PROMIS NEUROSCIENCES, INC. | Biotechnology | Chief Executive Officer Chairman | |
| Clarion University of Pennsylvania | College/University | Undergraduate Degree | |
| Montclair State University | College/University | Undergraduate Degree Undergraduate Degree | |
| New York University | College/University | Undergraduate Degree Masters Business Admin | |
| Princeton University | College/University | Undergraduate Degree Undergraduate Degree | |
| University of Maryland | College/University | Undergraduate Degree Undergraduate Degree | |
| The Hebrew University of Jerusalem | College/University | Doctorate Degree Doctorate Degree | |
National Cancer Institute
 National Cancer Institute Investment Trusts/Mutual FundsMiscellaneous National Cancer Institute provides healthcare services. It specializes in different cancer treatment such as adrenocortical carcinoma, anal cancer, appendix cancer, skin cancer, breast cancer, cardiac tumors, endometrial cancer, and gallbladder cancer. The company was founded in March 1937 and is headquartered in Bethesda, MD. | Investment Trusts/Mutual Funds | Corporate Officer/Principal Corporate Officer/Principal | |
| North Carolina State Ports Authority | General Government | Director/Board Member | |
| ESSEC Business School | College/University | Undergraduate Degree Graduate Degree | |
| École des Hautes Études Commerciales de Paris | College/University | Graduate Degree Masters Business Admin Undergraduate Degree | |
| ANAVEX LIFE SCIENCES CORP. | Biotechnology | Chief Executive Officer Chairman | |
Joslin Diabetes Center, Inc.
 Joslin Diabetes Center, Inc. Pharmaceuticals: MajorHealth Technology Joslin Diabetes Center, Inc. is a non-profit organization, which engages in the development of pharmaceuticals for diabetes. It provides adult care, pediatric care, eye care, and education programs and classes. The company was founded by Elliott P. Joslin in 1893 and is headquartered in Boston, MA. | Pharmaceuticals: Major | Corporate Officer/Principal President | |
Charlotte Regional Partnership
 Charlotte Regional Partnership Miscellaneous Commercial ServicesCommercial Services Charlotte Regional Partnership operates as a non-profit economic development organization. It serves as a catalyst for government and business collaboration to market and promote Charlotte USA for sustained, long-term growth, job creation, and investment opportunities. The company is headquartered in Charlotte, NC. | Miscellaneous Commercial Services | Chairman | |
EnzymeRx LLC
 EnzymeRx LLC BiotechnologyHealth Technology EnzymeRx LLC develops pegylated uricase for the treatment of resistant and refractory related indications. The company was founded by Anthony S Fiorino in 2008 and is headquartered in Paramus, NJ. | Biotechnology | Director of Finance/CFO Chief Executive Officer Chief Tech/Sci/R&D Officer | |
| BIOXYTRAN, INC. | Pharmaceuticals: Major | Director/Board Member Chief Executive Officer Director/Board Member Director/Board Member Director of Finance/CFO | |
| Harvard Business School | College/University | Masters Business Admin Masters Business Admin Graduate Degree | |
| ECOSLOPS SA | Trucking | Director/Board Member Director/Board Member | |
| TRAVERE THERAPEUTICS, INC. | Pharmaceuticals: Major | Director/Board Member Corporate Officer/Principal | |
| Virtua LLC | Founder Founder | ||
Blue Ox Healthcare Partners LLC
 Blue Ox Healthcare Partners LLC Investment ManagersFinance Blue Ox Healthcare partners LLC (Blue Ox Partners) is a private equity firm founded in 2009 by Oded Levy and Sheila Schweitzer. The firm is headquartered in New York. | Investment Managers | Corporate Officer/Principal | |
| The Leonard N Stern School of Business | College/University | Graduate Degree | |
Gemelli Biotech Corp.
 Gemelli Biotech Corp. BiotechnologyHealth Technology Gemelli Biotech Corp. engages in the development and manufacture of antibody blood test products. The firm offers ibs-smart products. The company was founded by Matthew Mitcho, Ali Rezaie, Ruchi Mathur, and Mark Pimentel in 2018 and is headquartered in Los Angeles, CA. | Biotechnology | Director/Board Member |
Statistik
International
| Vereinigte Staaten | 39 |
| Frankreich | 6 |
| Vereinigtes Königreich | 3 |
| Schweiz | 3 |
| Kanada | 3 |
Sektoral
| Health Technology | 23 |
| Consumer Services | 14 |
| Commercial Services | 5 |
| Finance | 3 |
| Non-Energy Minerals | 2 |
Operativ
| Director/Board Member | 251 |
| Corporate Officer/Principal | 170 |
| Independent Dir/Board Member | 67 |
| Chief Executive Officer | 66 |
| President | 51 |
Am stärksten vernetzte Beziehungen
| Insiders | |
|---|---|
| Anne Michelle Whitaker | 35 |
| Michael Friedman | 30 |
| Cameron Durrant | 25 |
| Brett Carter | 25 |
| Eric Nemeth | 23 |
| Elliot M. Maza | 21 |
| Henry Jemil Esber | 21 |
| Karin Hehenberger | 21 |
| George Poste | 21 |
| René Lerer | 20 |
| Lisa Gray | 19 |
| Hervé de Kergrohen | 19 |
| Jason Aryeh | 18 |
| René-Pierre Azria | 16 |
| Yannick Plétan | 14 |
- Börse
- Insiders
- Daniel Teper
- Unternehmensverbindungen
